Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. Freiwan A, Zoine JT, Crawford JC, Vaidya A, et al. Blood 2022;140:2684-2696.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Freiwan A, Zoine JT, Crawford JC, Vaidya A, et al. Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. Blood 2022;140:2684-2696.
PMID: 35914226